GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a major focus in medical studies, largely due to its notable impact on controlling conditions such as adult-onset diabetes and excess body fat. Recent studies have revealed that more than glucose management, GLP-1 drugs offer potential for cardiovascular well-being and even